Researchers sought to understand the perceptions of adolescents and young adults with cancer, their caregivers, and their healthcare team regarding meals while undergoing treatment.
As myeloproliferative neoplasms (MPNs) are a rare form of blood cancer, patients may not be aware of its effects. How do MPNs affect a patient’s quality of life, and what do your patients need to know?
A survey of providers from multiple disciplines directly involved in care of patients with NSCLC revealed gaps and barriers to care in a diverse selection of cancer programs.
The 2-year actuarial rate of local recurrence was 4.8%.
Tyrosine kinase inhibitors have improved survival outcomes for patients with CML, but these agents also have a greater risk for adverse cardiovascular events.
Researchers sought to determine whether IRF4 expression is associated with an increased susceptibility to de novo AML and myelodysplastic syndrome.
Researchers sought to determine whether extramedullary lesions would be an indicator of prognosis in patients with multiple myeloma treated in the first line with bortezomib.
A retrospective study evaluated the effect of 5% imiquimod prior to Mohs surgery in patients with basal cell carcinoma.
A systematic review identified nursing tips for the care of pediatric patients at risk of cytokine release syndrome after blinatumomab or CAR-T therapy.
Researchers characterized incidence and factors linked to cerebral venous thrombosis associated with myeloproliferative neoplasms.
Researchers identified prognostic factors for improved overall survival in patients treated with palbociclib and fulvestrant for advanced breast cancer.
Researchers found preoperative blood glucose levels were associated with hospital length of stay for patients undergoing laparoscopic nephrectomy for RCC.
The mortality rate was significantly higher in the lockdown phase than in the lockdown-lifted phase.
For patients with low- or intermediate-risk disease, the risk of dying from CLL progression was similar to the risk of dying from CLL-related complications or from causes unrelated to CLL.
Researchers found links between smoking cessation and survival outcomes among patients who were smokers at the time of non-small cell lung cancer diagnosis.
Editorialists questioned the quality of the data set.
Researchers sought to describe symptoms experienced by pediatric patients receiving palliative care based on parent-reported data.
For patients with cancer and chronic constipation, elobixibat was shown to be safe and effective during an observational study, the results of which were published in The Oncologist. Chronic constipation affects up to 87% of patients with cancer receiving palliative care and has been associated with reduced quality of life and extreme discomfort. To address…
The approval was based on data from the phase 3 ASPEN trial.
The median overall survival was not reached at a median follow-up of 22.9 months.